FR2261011A1 - - Google Patents

Info

Publication number
FR2261011A1
FR2261011A1 FR7504950A FR7504950A FR2261011A1 FR 2261011 A1 FR2261011 A1 FR 2261011A1 FR 7504950 A FR7504950 A FR 7504950A FR 7504950 A FR7504950 A FR 7504950A FR 2261011 A1 FR2261011 A1 FR 2261011A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7504950A
Other versions
FR2261011B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2261011A1 publication Critical patent/FR2261011A1/fr
Application granted granted Critical
Publication of FR2261011B1 publication Critical patent/FR2261011B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7504950A 1974-02-19 1975-02-18 Expired FR2261011B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH227674 1974-02-19

Publications (2)

Publication Number Publication Date
FR2261011A1 true FR2261011A1 (fr) 1975-09-12
FR2261011B1 FR2261011B1 (fr) 1978-07-21

Family

ID=4229973

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7504950A Expired FR2261011B1 (fr) 1974-02-19 1975-02-18

Country Status (17)

Country Link
US (1) US4020162A (fr)
JP (1) JPS50129724A (fr)
AT (1) AT336793B (fr)
BE (1) BE825656A (fr)
CA (1) CA1052270A (fr)
DE (1) DE2506579A1 (fr)
DK (1) DK138974B (fr)
ES (1) ES434805A1 (fr)
FR (1) FR2261011B1 (fr)
GB (1) GB1494558A (fr)
IE (1) IE40663B1 (fr)
LU (1) LU71862A1 (fr)
MX (1) MX3044E (fr)
NL (1) NL7501248A (fr)
PH (1) PH11892A (fr)
SE (1) SE434457B (fr)
ZA (1) ZA751016B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004106A1 (fr) * 1984-03-14 1985-09-26 Corbiere Jerome Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues
EP0253226A1 (fr) * 1986-07-12 1988-01-20 Roche Diagnostics GmbH Solution injectable aqueuse alcaline de torasemide prête à l'emploi et son procédé de préparation

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
JPS61130228A (ja) * 1984-11-29 1986-06-18 Sunstar Inc ミノサイクリンを安定に配合した組成物
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
AU2006252616B2 (en) * 2005-05-31 2011-05-19 Warsaw Orthopedic, Inc. Compositions and methods for treating pain
US8945623B2 (en) 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) * 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US8858924B2 (en) * 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
US9244060B2 (en) * 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
WO2010111212A1 (fr) 2009-03-26 2010-09-30 Warsaw Orthopedic, Inc. Procédés d'identification de composants potentiels pour compositions de délivrance ciblée de médicament
US8852566B2 (en) 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004106A1 (fr) * 1984-03-14 1985-09-26 Corbiere Jerome Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues
EP0253226A1 (fr) * 1986-07-12 1988-01-20 Roche Diagnostics GmbH Solution injectable aqueuse alcaline de torasemide prête à l'emploi et son procédé de préparation
US4861786A (en) * 1986-07-12 1989-08-29 Boehringer Mannheim Gmbh Composition for a stable vein compatible injectable solution of torasemide process for the preparation and method of use

Also Published As

Publication number Publication date
GB1494558A (en) 1977-12-07
PH11892A (en) 1978-08-29
SE434457B (sv) 1984-07-30
ZA751016B (en) 1976-01-28
BE825656A (fr) 1975-08-18
ATA119375A (de) 1976-09-15
JPS50129724A (fr) 1975-10-14
NL7501248A (nl) 1975-08-21
FR2261011B1 (fr) 1978-07-21
DE2506579A1 (de) 1975-08-21
AT336793B (de) 1977-05-25
DK138974C (fr) 1979-05-07
DK4375A (fr) 1975-10-20
CA1052270A (fr) 1979-04-10
IE40663B1 (en) 1979-07-18
US4020162A (en) 1977-04-26
DK138974B (da) 1978-11-27
MX3044E (es) 1980-03-04
LU71862A1 (fr) 1975-12-09
ES434805A1 (es) 1976-12-01
AU7830775A (en) 1976-08-19
IE40663L (en) 1975-08-19

Similar Documents

Publication Publication Date Title
FR2423825B1 (fr)
DK138974C (fr)
FR2270202A1 (fr)
JPS50100322A (fr)
FI752595A (fr)
FR2263362B1 (fr)
FR2284397B3 (fr)
JPS50103960A (fr)
FR2263912B1 (fr)
JPS50104661A (fr)
FR2279731B1 (fr)
JPS50107939A (fr)
FR2268406B1 (fr)
JPS50121307U (fr)
JPS50120245U (fr)
JPS50109770U (fr)
JPS50131087U (fr)
JPS50131707U (fr)
CH578234A5 (fr)
CH577817A5 (fr)
BG21133A1 (fr)
BG26001A3 (fr)
BG21288A1 (fr)
BG21290A1 (fr)
BG20459A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse